pharma · No medical condition. · Generalized Myasthenia Gravis
Anaxis Pharma
Lacuna Pharma Pty Ltd
Lacuna Pharma Pty is a pharma organization headquartered in Colmenar Viejo, AU. Primary therapeutic focus areas include No medical condition., Generalized Myasthenia Gravis, No therapeutic indication in the current trial
Melbourne, AU HQ
2017 Founded
7 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Melbourne, AU
- Founded
- 2017
- Employees
- 7
- Programs
- 642
- Drugs
- 673
- Patents
- 0
LP352-303
Phase 3 · small molecule · Developmental and Epileptic Encephalopathies (DEEs)
LP352-303 for Developmental and Epileptic Encephalopathies (DEEs) is a Phase 3 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code LP352-303
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Lacuna Pharma Pty Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Developmental and Epileptic Encephalopathies (DEEs)
- Status
- active
- Trials
- 1